About Edward Mathers
Form D filings for Cardurion Pharmaceuticals in 2024 list Edward Mathers as director.
Edward Mathers first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Edward Mathers in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Edward Mathers works with at each company, as listed on that company's latest Form D.
Cardurion Pharmaceuticals, Inc. · Form D, Jul 24, 2024
ER
Evan Rachlin
Director
Jeb Keiper
Director
MM
Michael Mendelsohn
Executive officer and director
DL
Daniel Lynch
Director
ER
Emma Reeve
Director
PL
Peter Lawrence
President and Chief Executive Officer, director
AK
Adam Koppel
Director
ND
Nicholas Downing
Director